EP Patent

EP2233135B8 — Use of a beta blocker for the manufacture of a medicament for the treatment of hemangiomas

Assigned to Universite Victor Segalen Bordeaux 2 · Expires 2013-07-10 · 13y expired

What this patent protects

Patent listed against propranolol-hydrochloride.

Drugs covered by this patent

propranolol-hydrochloride (PROPRANOLOL HYDROCHLORIDE)

Patent Metadata

Patent number: EP2233135B8
Jurisdiction: EP
Classification: —
Expires: 2013-07-10
Drug substance claim: No
Drug product claim: No
Assignee: Universite Victor Segalen Bordeaux 2
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.